Bausch Health Companies Mergers and Acquisitions Summary

Life Science Company

Bausch Health Companies has acquired 39 companies, including 5 in the last 5 years. A total of 13 acquisitions came from private equity firms. It has also divested 9 assets.

Bausch Health Companies’ largest acquisition to date was in 2015, when it acquired Salix Pharmaceuticals for $14.5B. It’s largest disclosed sale occurred in 2017, when it sold iNova Pharmaceuticals Pty to The Carlyle Group for $930M. Bausch Health Companies has acquired in 10 different US states, and 11 countries. The Company’s most targeted sectors include life science (59%) and medical products (21%).

Join Mergr and gain access to Bausch Health Companies’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity43
    • M&A Buy Activity34
    • M&A Sell Activity9
  • Total Sectors Invested 4
  • Total Countries Invested 11
  • M&A Buy/Sell Connections 30
  • M&A Advisors 17

Bausch Health Companies, Inc.

2150 St. Elzéar Boulevard West,
Laval, Quebec H7L 4A8
Canada,
(514) 744-6792
www.bauschhealth.com

Bausch Health Companies, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health Companies was founded in 1983 and is headquartered in Laval, Canada.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.2/yr) # 33 - - - 1 - 34
vol $32.6B $195M $32.8B
Sell (1.2/yr) # 3 - 6 - - - 9
vol $49M $1.9B $2.0B
  43

Most Recent M&A

Company Date Value Type
Synergy Pharmaceuticals, Inc. - Certain Assets 2019-02-26 195M USD Divestiture
New York, New York
Obagi Medical Products, Inc. 2017-11-10 190M USD Divestiture
Long Beach, California · www.obagi.com
iNova Pharmaceuticals (Australia) Pty Ltd. 2017-06-08 930M USD Divestiture
Chatswood, Australia · www.inovapharma.com
CeraVe 2017-01-10 - Divestiture
Bridgewater, New Jersey · www.cerave.com
Acnefree 2017-01-10 - Divestiture
Bridgewater, New Jersey · www.acnefree.com
Valeant Pharmaceuticals - AMBI Skincare 2017-01-10 - Divestiture
Bridgewater, New Jersey
Dendreon Pharmaceuticals, Inc. 2017-01-09 820M USD Divestiture
Seattle, Washington · www.dendreon.com
Synergetics USA, Inc. 2015-10-15 - Add-on Acquisition
O’Fallon, Montana · www.synergeticsusa.com
Sprout Pharmaceuticals, Inc. 2015-08-20 1.0B USD Add-on Acquisition
Raleigh, North Carolina · www.sproutpharma.com
Amoun Pharmaceutical Company S.A.E. 2015-07-17 800M USD Add-on Acquisition
Cairo, Egypt · www.amoun.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Synergetics USA, Inc. 2015-10-15 Synergetics USA, Inc. - Neuro Portfolio 2016-02-10 1
O’Fallon, Montana · www.synergeticsusa.com O’Fallon, Montana

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 20 (59%) 21.8B (66%) 3 (33%) 1.7B (88%)
Consumer Products 5 (15%) 422M (1%) 4 (44%) -
Medical Products 7 (21%) 10.6B (32%) 1 (11%) 190M (10%)
Healthcare Services 2 (6%) 20M (< 1%) - -
Technology Hardware - - 1 (11%) 49M (2%)
Total 34 $32.8B 9 $2.0B

By Geo

State/Country Buy Value Sell Value
United States 21 30.6B 7 1.1B
  New Jersey 5 1.1B 3 -
  California 5 1.3B 2 239M
  New York 3 8.9B - -
  North Carolina 2 15.5B - -
  Washington 1 400M 1 820M
  Rhode Island 1 475M - -
  Pennsylvania 1 312M - -
  Montana 1 - - -
  Florida 1 28M - -
  Arizona 1 2.6B - -
Australia 2 498M 1 930M
Canada 3 9M - -
  Ontario 2 9M - -
  Quebec 1 - - -
Austria 1 - - -
Brazil 1 41M - -
Egypt 1 800M - -
India - - 1 -
Lithuania 1 - - -
Mexico 1 - - -
Russia 1 163M - -
Switzerland 1 394M - -
United Kingdom 1 300M - -
Domestic 3 (9%) 9M (< 1%) - -
Cross-border 31 (91%) 32.8B (100%) 9 (100%) 2.0B (100%)
Total 34 $32.8B 9 $2.0B

Top M&A Advisors

Financial Deals
Morgan Stanley
1
Goldman Sachs Investment Banking Division
1
Jefferies LLC
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom LLP
6
Sullivan & Cromwell LLP
3
Norton Rose Fulbright LLP
1

Deal Values

buy # Total
> $1B 4 $26.8B
$100M to $1B 16 $5.8B
< $100M 7 $215M
TOTAL $32.8B
Largest Salix Pharmaceuticals Ltd.
$14.5B (2015-02-22)
sell # Total
$100M to $1B 3 $1.9B
< $100M 1 $49M
TOTAL $2.0B
Largest iNova Pharmaceuticals (Australia) Pty Ltd.
$930M (2017-06-08)

M&A Connections

Deals %
Acquired from
PE Firm(s)
59%
13 59%
Strategic(s)
41%
9 41%
Divested to
PE Firm(s)
40%
4 40%
Strategic(s)
60%
6 60%

 Subscribe to unlock this and 151,932
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 139K M&A Transactions
  • 148K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 41K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.